15.12.2010 • News

Hadasit Bio-Holdings is an Investment Interest for Sanofi-Aventis

French drugmaker Sanofi-Aventis is in talks to invest in Hadasit Bio-Holdings, the Israeli biotech holding company said on Tuesday.

Hadasit said the potential investment would be in its KHAR Medical unit, but that no deal had yet been reached. It noted that it was responding to a report in Israel's Calcalist newspaper.

Hadasit, the technology transfer company of Jerusalem's Hadassah University Hospital, said the deal could be thwarted by the disclosure of the talks in the newspaper.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read